News
Prime Medicine, Inc. achieved strong early data in CGD with PM359, surpassing efficacy thresholds. Click here to find out why ...
Bacteria and their phage, “are full of mysteries and also lots of really powerful mechanisms that we can study and potentially harness.” ...
13h
Zacks.com on MSNIntellia Gains 29.8% in a Month: How Should You Play the Stock?Intellia Therapeutics NTLA has put up a stellar performance in the past month. Shares of the company have rallied 29.8% compared with the industry’s rise of 0.4%. The stock has also outperformed the ...
New research has found a novel target with therapeutic potential for metastatic eye melanoma—an aggressive eye cancer—with ...
CRISPRware is a new tool scientists can use to design the best guide RNAs to edit genes in many organisms, without the need for deep bioinformatics expertise. By making gene editing more precise and ...
Wave Life Sciences Ltd. shows promise with AATD, DMD, and Huntington's programs. Click for my updated look at WVE stock and ...
17h
United News of Bangladesh on MSNCRISPR gene editing reshaping medicine, offering hope for genetic diseasesCRISPR technology is transforming modern medicine by enabling precise DNA editing to treat genetic disorders, including sickle cell anemia and beta-thalassemia, experts say.
Cancer can be reversed. Yes, you heard it right. In a remarkable breakthrough, a team of scientists from the Korea Advanced Institute of Science and Technology ...
Franklin W. Stahl, an American molecular biologist whose landmark 1957-58 experiment with colleague Matthew Meselson revealed ...
Months after announcing an M&A deal with AstraZeneca, EsoBiotec has released the first small slice of data on the cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results